Anonymous authorship may reduce prescription drug deaths

I just published the article, Anonymous authorship may reduce prescription drug deaths, in Ind J Med Ethics, online first. I argue why the current peer review system is unfair and invites abuse and give examples of misconduct at the FDA and in drug companies which has caused hundreds of thousands of deaths we could have avoided.

I very much hope you will read my paper and open a much needed discussion of why we not only need anonymous whistleblowers but also anonymous authors to protect public health and scientific freedom and freedom of speech. Please also look up upcoming articles about this subject in the journal,

The decline in scientific freedom has been particularly visible during the COVID-19 pandemic. The Institute for Scientific Freedom in Copenhagen and Centre for Evidence-Based Medicine in Oxford will therefore hold a joint conference with the title above in Copenhagen 24-25 October 2022. We hope to see you.